Picture of COSCIENS Biopharma logo

CSCI — COSCIENS Biopharma News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Aeterna Zentaris Announces European Licensing Agreement With Consilient Health Ltd For Commercialization Of Macimorelin

Dec 7 (Reuters) - Aeterna Zentaris Inc  AEZS.TO :
    * AETERNA ZENTARIS ANNOUNCES EUROPEAN LICENSING AGREEMENT
WITH
CONSILIENT HEALTH LTD. FOR COMMERCIALIZATION OF MACIMORELIN
    * AETERNA ZENTARIS INC - AETERNA WILL CONTINUE TO MAINTAIN
CONTROL
OF ITS PATENTS COVERING MACIMORELIN IN EUROPE AND UNITED KINGDOM
    * AETERNA ZENTARIS INC - CONSILIENT HEALTH WILL MAKE AN
UP-FRONT
PAYMENT TO AETERNA OF EURO 1 MILLION
    * AETERNA ZENTARIS INC -  CONSILIENT HEALTH WILL PAY TO
AETERNA
ROYALTIES ON NET SALES OF MACIMORELIN RANGING FROM 10% TO 20%

Source text for Eikon:  ID:nGNX9CKyc3 
Further company coverage:  AEZS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on COSCIENS Biopharma

See all news